The objective of this revised renewal application is to improve our understanding of the molecular mechanisms responsible for abnormal dehydration of sickle red cells, arguably the most important cellular defect of these cells and further clarifying the role of iron and oxidation as pathogenetic influences in sickle cell disease. The proposal comprises of two subprojects that are interrelated in that they both are relevant to problems of cation homeostasis and of oxidative pathobiology. The study on the role of oxidation in sickle disease pathophysiology has three specific aims: 1) Identify the reason for increased """"""""autoxidation"""""""" of sickle hemoglobin, considering that it derives not from an inherent autoxidative instability but rather from interaction of sickle hemoglobin with transition metals, pathophysiologic oxidants, and membrane phospholipid; 2) Define the nature of iron decompartmentalization in sickle red cells by assessing: cytoplasmic free transition metal content and its relationship to membrane-free iron, as well as equilibrium binding of iron as influenced by cytosolic physiologic chelators; the role of metal/hemoglobin/membrane interaction in membrane iron deposition; and iron compartments as a function of genotype; 3) Test predictions about the biochemical consequences of such oxidative processes including the validating of hypotheses: that unstable hemoglobinopathy membranes are sickle- like; and that removal of red cell membrane iron using an iron chelator should effect predictable improvements, an approach that will test a potential therapeutic option. The study on the role of membrane deformation-induced cation leak from red cells has three specific aims: 1) Define mechanisms explaining the unique features of the leak resulting from hypotonic deformation. The leading hypothesis to be tested is that macromolecular crowding exerts a major influence on membrane's response to deformation; 2) Establish the relationship of this model to authentic sickling by testing the prediction that the qualitative character of the sickling-induced leak will depend on the degree of deformation; detailing its comparative phenomenology; and determining its relationship to membrane lipid hydroperoxides; and 3) Approach the question as to whether red cell mechanosensitivity occurs by design or accident by examining the deformation response of selected red cells with known leak pathway deficiencies; and by using zinc treated red cells to examine the hypothesis that a permissive mechanosensitive leak structure is formed by clustering of Band 3 protein. It is anticipated that successful accomplishment of these objectives will contribute to a significant improvement in our understanding of the molecular basis for sickle red cell membrane pathobiology and cell dehydration and could also lead to novel therapeutic approaches to sickle cell disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL037528-13
Application #
2883225
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1986-09-30
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2001-02-28
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Shalev, O; Hileti, D; Nortey, P et al. (1999) Transport of 14C-deferiprone in normal, thalassaemic and sickle red blood cells. Br J Haematol 105:1081-3
Browne, P; Shalev, O; Hebbel, R P (1998) The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med 24:1040-8
Sheng, K; Shariff, M; Hebbel, R P (1998) Comparative oxidation of hemoglobins A and S. Blood 91:3467-70
Cragg, L; Hebbel, R P; Miller, W et al. (1998) The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells. Blood 92:632-8
Shalev, O; Hebbel, R P (1996) Extremely high avidity association of Fe(III) with the sickle red cell membrane. Blood 88:349-52
Shalev, O; Hebbel, R P (1996) Catalysis of soluble hemoglobin oxidation by free iron on sickle red cell membranes. Blood 87:3948-52
Enright, H; Miller, W J; Hays, R et al. (1996) Preferential targeting of oxidative base damage to internucleosomal DNA. Carcinogenesis 17:1175-7
Browne, P V; Mosher, D F; Steinberg, M H et al. (1996) Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 51:296-301
Shalev, O; Repka, T; Goldfarb, A et al. (1995) Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 86:2008-13
Sugihara, T; Yawata, Y; Hebbel, R P (1994) Deformation of swollen erythrocytes provides a model of sickling-induced leak pathways, including a novel bromide-sensitive component. Blood 83:2684-91

Showing the most recent 10 out of 22 publications